Chimäre Dengue/zika-Viren als Attenuierte Zikavirus Lebendimpfstoffe
EP3481849
Art B1
10. Dezember 2025
Anmelder: The United States of America, as represented by the Secretary, Department of Health and Human Services, The United States of America, as represented by the Secretary, Department of Health and Human Services, National Institutes of Health, The U.S.A. as represented by the Secretary, Department of Health and Human Services 🇺🇸
Details
- Veröffentlichungs-Nr.
- EP3481849
- Aktenzeichen
- EP17740574
- Anmeldetag
- 6. Juli 2017
- Veröffentlichung
- 10. Dezember 2025
- Erteilung
- 10. Dezember 2025
- Rechtsraum
- EP
- IPC
- C07K14/005C12N7/00A61K39/12
Abstract
Für dieses Patent liegt uns kein Abstract vor.
Anmelder
- Firmen
- The United States of America, as represented by the Secretary, Department of Health and Human Services
The United States of America, as represented by the Secretary, Department of Health and Human Services, National Institutes of Health
The U.S.A. as represented by the Secretary, Department of Health and Human Services - Land
- 🇺🇸 USA
Vertreten von
Gowshall, Jonathan Vallance
München, Deutschland
1.256
Patente gesamt
28
Fachgebiete
24
Anmelder-Länder
Schwerpunkte
Weitere Vertreter
-
Forresters IP LLP
Forresters IP LLP · München